Dr. Richard Harold Gentry, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 112 N Walnut Ave, Cookeville, TN 38501 Phone: 931-520-1414 Fax: 931-520-1246 |
Lisa M Whiteaker, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1120 Perimeter Park Dr, Cookeville, TN 38501 Phone: 931-528-0002 Fax: 931-528-1515 |
Dr. Richard Scott Hall, M.D. Dermatology - MOHS-Micrographic Surgery Medicare: Accepting Medicare Assignments Practice Location: 112 N Walnut Ave, Cookeville, TN 38501 Phone: 931-520-1414 Fax: 931-520-1246 |
News Archive
The study "Oxidative Stress is an Important Component of Airway Inflammation in Mice Exposed to Cigarette Smoke or Lipopolysaccharide" investigates the inflammatory responses in oxidative stress-deficient mice exposed to cigarette smoke.
Dapagliflozin, a drug that is already used to successfully treat type 2 diabetes (T2D) and prevent development of heart failure, can also be used to treat pre-existing heart failure, even in patients without T2D.
The Feinstein Institute for Medical Research has been awarded a $1 million grant from the World Trade Center Health Program, which is administered by the National Institute for Occupational Safety and Health, part of the US Centers for Disease Control and Prevention, the National Institute for Occupational Safety and Health and Safety to comprehensively study the overall physical, mental and socioeconomic impact of the World Trade Center (WTC) disaster on responders, as well as identify the linkage between socioeconomic status and health among all occupations of WTC responders.
The Maryland insurance commissioner Therese M. Goldsmith approved premium increases Friday for nine insurance companies who applied to sell plans to individuals through a state exchange, which was established by the health law.
In a Guest Editorial published in the new publication Clinical Investigation, Dr Jeffrey Weitz and Dr John Eikelboom of McMaster University in Hamilton, Canada highlight the importance of the approval in October by the FDA of dabigatran etexilate (Pradaxa®; Boehringer Ingelheim). This new oral thrombin inhibitor provides an alternative to warfarin for long-term stroke prevention in patients with non-valvular atrial fibrillation.
› Verified 6 days ago